Hematuria natural history, complications and prognosis

Revision as of 14:36, 22 August 2018 by Okamal (talk | contribs)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]

Overview

The prognosis depends on the severity of the disease. Finding the cause is the main factor which determines the prognosis. As hematuria has a vast majority of causes the complications depends on the specific etiology.[1]

Natural history, Complications and Prognosis

Natural history, complications and prognosis of hematuria and microscopic hematuria depends on the severity of the disease. Finding the cause is the main factor which determines the prognosis. As hematuria has a vast majority of causes, the complications depends on the specific etiology.The rate of malignancy detected among patients evaluated for a single positive urinalysis was 3.6%. Thus the most recent AUA guideline panel has determined that a single positive urinalysis is sufficient to prompt evaluation.[1]The prognosis in asymptomatic isolated hematuria is good.

Natural History

  • The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
  • The symptoms of (disease name) typically develop ___ years after exposure to ___.
  • If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].

Complications

  • Common complications of [disease name] include:
    • [Complication 1]
    • [Complication 2]
    • [Complication 3]

Prognosis

  • Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
  • Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
  • The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
  • [Subtype of disease/malignancy] is associated with the most favorable prognosis.
  • The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.

References

  1. 1.0 1.1 Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ et al. (2012) Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 188 (6 Suppl):2473-81. DOI:10.1016/j.juro.2012.09.078 PMID: 23098784

Template:WH Template:WS